Literature DB >> 30854303

Establishing auditory-tactile-visual equivalence classes in children with autism and developmental delays.

Stuart Mullen1, Mark R Dixon1, Jordan Belisle1, Caleb Stanley1.   

Abstract

The current study sought to evaluate the efficacy of a stimulus equivalence training procedure in establishing auditory-tactile-visual stimulus classes with 2 children with autism and developmental delays. Participants were exposed to vocal-tactile (A-B) and tactile-picture (B-C) conditional discrimination training and were tested for the emergence of vocal-picture (A-C) and picture-vocal (C-A) responses. The results demonstrated that, following training, both participants responded successfully on both the training stimulus arrangements and the test probes that were never trained, illustrating emergence of cross-modal transitive and equivalence relations.

Entities:  

Keywords:  Cross-modal equivalence; PEAK relational training; Stimulus equivalence; Tactile stimuli

Year:  2017        PMID: 30854303      PMCID: PMC6381331          DOI: 10.1007/s40616-017-0092-8

Source DB:  PubMed          Journal:  Anal Verbal Behav        ISSN: 0889-9401


  4 in total

1.  Teaching early braille literacy skills within a stimulus equivalence paradigm to children with degenerative visual impairments.

Authors:  Karen A Toussaint; Jeffrey H Tiger
Journal:  J Appl Behav Anal       Date:  2010

2.  The efficiency and efficacy of equivalence-based learning: A randomized controlled trial.

Authors:  Tracy E Zinn; M Christopher Newland; Katie E Ritchie
Journal:  J Appl Behav Anal       Date:  2015-09-28

Review 3.  Toward a technology of derived stimulus relations: an analysis of articles published in the journal of applied behavior analysis, 1992-2009.

Authors:  Ruth Anne Rehfeldt
Journal:  J Appl Behav Anal       Date:  2011

4.  Conditional discrimination vs. matching to sample: an expansion of the testing paradigm.

Authors:  M Sidman; W Tailby
Journal:  J Exp Anal Behav       Date:  1982-01       Impact factor: 2.468

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.